Biopharmaceutical company Bicycle Therapeutics plc (BCYC) announced on Friday that it has appointed Alethia Young as its chief financial officer, effective July 17.
Young is succeeding Lee Kalowski who has served as the company's finance chief since 2017.
Alethia is joining Bicycle from Graphite Bio, where she has been serving as the chief financial officer.
She has more than 20 years of experience in the healthcare and biotech sectors and has worked in companies like Cantor Fitzgerald, Credit Suisse, and Deutsche Bank.
The company also announced the promotion of Travis Thompson currently serving as the Senior Vice President, Finance to senior vice president, chief accounting officer. He will work alongside Alethia Young.
Currently, shares of Bicycle are trading at $27.29 up 1.34% or $0.36 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.